Rapid Weight Loss Brings Expanding Soft Tissue Concerns to Dermatology

Key Takeaways

• Rapid weight loss from GLP-1 agents, bariatric surgery, or lifestyle change is associated with measurable declines in skin elasticity and soft tissue volume, new research indicates.
• Structural effects extend beyond dermal changes to include muscle loss and decreased bone density.
• Multimodal management strategies—from nutrition to energy-based devices and surgery—are emerging but remain variably supported by evidence.

A new analysis suggests rapid weight loss from GLP-1 agents, bariatric surgery, or lifestyle change is associated with measurable declines in skin elasticity and soft tissue volume.

Rapid and intentional weight loss (driven by bariatric surgery, glucagon-like peptide-1 (GLP-1) receptor agonists, or intensive lifestyle changes) has introduced a growing set of dermatologic and structural considerations for clinicians. Fathizadeh et al published the narrative review in the Journal of Drugs in Dermatology evaluate the downstream effects of weight reduction on soft tissue integrity and outline current management approaches.

The review included literature from 2000 to 2025 focused on changes in collagen, elastic fibers, adipose tissue, muscle mass, and bone structure. Rapid weight loss was consistently associated with reduced dermal support, manifesting clinically as skin laxity, decreased firmness, and volume depletion across the surveyed research. Changes were compounded by reductions in muscle mass and bone density.

Turnign to management strategies, Fathizadeh et al pointed to preventive and corrective approaches. Nutritional optimization and resistance-based exercise were foundational interventions for the mitigation of muscle and structural loss. In the aesthetic setting, energy-based devices and biostimulatory injectables are increasingly used to address skin laxity and volume deficits, but evidence remains heterogeneous. Surgical procedures were noted as options in advanced cases. Regenerative therapies are also under investigation but currently lack robust clinical validation.

“As rapid weight loss becomes increasingly common, dermatologists are encountering a broader range of cosmetic and structural concerns,” the authors wrote. “A multidisciplinary, evidence-informed approach is critical for addressing these issues and improving patient outcomes.”

Source: Fathizadeh S, et al. Journal of Drugs in Dermatology. 2026;25(5);449.